Dr. Sun is a highly trained medicinal chemist with a focus on multifunctional phosphonate based drug actives. She received her PhD in 2013 at the University of Southern California, Los Angeles, and is now the Chief Scientist at BioVinc. She has been the premier synthetic chemist for the past 6 years within the McKenna/Kashemirov research…
Dr. Lundy is a skilled histopathologist who has studied the biochemical and pharmacological mechanism of bone metabolism for over 35 years. He has extensive in vivo pharmacology expertise and a particularly strong knowledge of drug pharmacology on the skeleton. He has helped develop potent bone anabolic agents, and was involved in understanding the distribution and…
Dr. Ebetino has worked on bisphosphonates for over 30 years. He spent most of his industrial career at Procter & Gamble Pharmaceuticals and now serves as President and Chief Scientific Officer at BioVinc. He is a trained synthetic and medicinal chemist who was a member of the team that discovered and developed the drug risedronate…